LISATA THERAPEUTICS, INC. Payments to Acquire Investments
LISATA THERAPEUTICS, INC. (LSTA) reported Payments to Acquire Investments of $28 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-20.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2012-03-20
- LISATA THERAPEUTICS, INC. payments to acquire investments for the quarter ending 2011-12-31 was $1.00.
- LISATA THERAPEUTICS, INC. payments to acquire investments for the quarter ending 2011-09-30 was $3.00.
- LISATA THERAPEUTICS, INC. payments to acquire investments for the quarter ending 2010-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. payments to acquire investments for the quarter ending 2010-09-30 was -$6.26K.
- LISATA THERAPEUTICS, INC. payments to acquire investments for fiscal 2011 was $28.00, a 100.00% decline from fiscal 2010.
- LISATA THERAPEUTICS, INC. payments to acquire investments for fiscal 2010 was $2.42M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2011-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | $4.00 derived: sum of 2 quarters · filed 2012-03-20 | $28.00 10-K · filed 2012-03-20 | |
| 2011-09-30 | $3.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $27.00 10-Q · filed 2011-11-10 | ||
| 2011-06-30 | $24.00 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | -$6.26K derived: sum of 2 quarters · filed 2012-03-20 | $2.42M 10-K · filed 2012-03-20 | |
| 2010-09-30 | -$6.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $2.42M 10-Q · filed 2011-11-10 | ||
| 2010-06-30 | $2.43M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |